Matthew A Nix

ORCID

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Venues

Nature

Nature cancer

Proceedings of the National Academy of Sciences of the United States of America

Leukemia

UCSF Medical Center

This page only lists publications with an associated author ORCID identifier.

Affiliation History

UCSF Medical Center Feb 01 2015

United States

Postdoctoral Scholar :: Laboratory Medicine

Publications

Kamal Mandal, Gianina Wicaksono, Clinton Yu, Jarrett J Adams, Michael R Hoopmann, William C Temple, Adila Izgutdina, Bonell Patiño Escobar, Maryna Gorelik, Christian H Ihling, Matthew A Nix, Akul Naik, William H Xie, Juwita Hübner, Lisa A Rollins, Sandy M Reid, Emilio Ramos, Corynn Kasap, Veronica Steri, Juan Antonio Camara Serrano, Fernando Salangsang, Paul Phojanakong, Melanie McMillan, Victor Gavallos, Andrew D Leavitt, Aaron C Logan, Cliona M Rooney, Justin Eyquem, Andrea Sinz, Benjamin S Braun, Elliot Stieglitz, Catherine C Smith, Robert L Moritz, Sachdev S Sidhu, Lan Huang, Arun P Wiita
Structural surfaceomics reveals an AML-specific conformation of integrin β 2 as a CAR T cellular therapy target. Nature cancer (2023)
Matthew A Nix, Kamal Mandal, Huimin Geng, Neha Paranjape, Yu-Hsiu T Lin, Jose M Rivera, Makeba Marcoulis, Kristie L White, Jeffrey D Whitman, Sagar P Bapat, Kevin R Parker, Jonathan Ramirez, Anne Deucher, Paul Phojanokong, Veronica Steri, Faranak Fattahi, Byron C Hann, Ansuman T Satpathy, Aashish Manglik, Elliot Stieglitz, Arun P Wiita
Surface Proteomics Reveals CD72 as a Target for In Vitro-Evolved Nanobody-Based CAR-T Cells in KMT2A/MLL1-Rearranged B-ALL. Cancer discovery 11 (8) (2021)
Jaewoong Lee, Mark E Robinson, Ning Ma, Dewan Artadji, Mohamed A Ahmed, Gang Xiao, Teresa Sadras, Gauri Deb, Janet Winchester, Kadriye Nehir Cosgun, Huimin Geng, Lai N Chan, Kohei Kume, Teemu P Miettinen, Ye Zhang, Matthew A Nix, Lars Klemm, Chun-Wei David Chen, Jianjun Chen, Vishal Khairnar, Arun P Wiita, Andrei Thomas-Tikhonenko, Michael Farzan, Jae U Jung, David M Weinstock, Scott R Manalis, Michael S. Diamond, Nagarajan Vaidehi, Markus Müschen
IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells. Nature 588 (7838) (2020)
Lai N Chan, Mark A Murakami, Mark E Robinson, Rebecca Caeser, Teresa Sadras, Jaewoong Lee, Kadriye Nehir Cosgun, Kohei Kume, Vishal Khairnar, Gang Xiao, Mohamed A Ahmed, Eamon Aghania, Gauri Deb, Christian Hurtz, Seyedmehdi Shojaee, Chao Hong, Petri Pölönen, Matthew A Nix, Zhengshan Chen, Chun Wei Chen, Jianjun Chen, Andreas Vogt, Merja Heinäniemi, Olli Lohi, Arun P Wiita, Shai Izraeli, Huimin Geng, David M Weinstock, Markus Müschen
Signalling input from divergent pathways subverts B cell transformation. Nature 583 (7818) (2020)
Anum Azam Glasgow, Jeff E Glasgow, Daniel Limonta, Paige Solomon, Irene Lui, Sunny Zhang, Matthew A Nix, Nicholas J Rettko, Beth Shoshanna Zha, Rachel Yamin, Kevin Kao, Oren S Rosenberg, Jeffrey V Ravetch, Arun P Wiita, Kevin K Leung, Shion An Lim, Xin X Zhou, Tom C Hobman, Tanja Kortemme, James A Wells
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America 117 (45) (2020)
Vishesh Sarin, Katharine Yu, Ian D Ferguson, Olivia Gugliemini, Matthew A Nix, Byron Hann, Marina Sirota, Arun P Wiita
Evaluating the efficacy of multiple myeloma cell lines as models for patient tumors via transcriptomic correlation analysis. Leukemia 34 (10) (2020)

Matthew A Nix.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Matthew A Nix